2016 Hematological Malignancies

HD15-PET trial Impact of response and PET status (TTP)

Time to progression 0.0 0.1 0.2 0.3 0.4 0.5 0.6 0.7 0.8 0.9 1.0 0

NPV@12m: 94% (95% CI: 92% to 96%)

PR ≥ 2.5cm/PET-

CR/CRu (no PET)

PR ≥ 2.5cm/PET+

12

24

36

48

60

Months from randomization

Pts. at Risk

540 188 854

517 166 811

449 139 690

338 97 482

224 58 303

118 35 155

PET- PET+ CR/CRu